# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Ricardo Rezende maintains Braskem (NYSE:BAK) with a Neutral and lowers the price target from $10 to $9.5.
Citigroup analyst Gabriel Barra upgrades Braskem (NYSE:BAK) from Neutral to Buy.
JP Morgan analyst Ricardo Rezende maintains Braskem (NYSE:BAK) with a Neutral and lowers the price target from $11 to $10.
Braskem (NYSE:BAK) reported $3.618 billion in sales this quarter. This is a 3.34 percent decrease over sales of $3.743 billion ...
The U.S. corporate bond market had mixed performance in Q1, with higher-rated bonds seeing slight declines and lower-rated bond...
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.